Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom - Reuters
Reuters Business·17h·Reputable
Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom Reuters
ChannelsstocksCountrieseurope, chinaCategoriesmergers-acquisitions
Open original source ↗Published
5/28/2026, 11:19:00 PM
Fetched
5/29/2026, 6:07:20 AM
Confidence
60 / 100
Relevance
47 / 100
Trust
reputable · 80/100
Language
en